0001181431-11-061105.txt : 20111219
0001181431-11-061105.hdr.sgml : 20111219
20111219150912
ACCESSION NUMBER: 0001181431-11-061105
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111215
FILED AS OF DATE: 20111219
DATE AS OF CHANGE: 20111219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ESHELMAN FREDRIC N
CENTRAL INDEX KEY: 0001033409
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34641
FILM NUMBER: 111269077
MAIL ADDRESS:
STREET 1: PPD INC
STREET 2: 929 NORTH FRONT STREET
CITY: WILMINGTON
STATE: NC
ZIP: 28401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Furiex Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001484478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271197863
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3900 PARAMOUNT PARKWAY
STREET 2: SUITE 150
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-456-7800
MAIL ADDRESS:
STREET 1: 3900 PARAMOUNT PARKWAY
STREET 2: SUITE 150
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: PPD Therapeutics, Inc.
DATE OF NAME CHANGE: 20100218
4
1
rrd328569.xml
FORM 4
X0304
4
2011-12-15
0
0001484478
Furiex Pharmaceuticals, Inc.
FURX
0001033409
ESHELMAN FREDRIC N
C/O FURIEX PHARMACEUTICALS, INC.
3900 PARAMOUNT PARKWAY, SUITE 150
MORRISVILLE
NC
27560
1
0
1
0
Common Stock
2011-12-15
4
P
0
17359
16.88
A
1977650
D
Common Stock
41666
I
GRAT
Common Stock
938
I
LLC
Common Stock
140
I
Spouse
Stock Options (to buy)
13.16
2021-10-03
Common Stock
98813
98813
I
LLC
Stock Options (to buy)
9.11
2020-06-17
Common Stock
197627
197627
I
LLC
This transaction was executed in multiple trades at prices ranging from $16.83 to $16.99. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
The options were awarded on 10/3/2011 and vest over three years, with one-third of the options vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
The options were awarded on 6/17/2010 and vest over three years, with one-third of the options vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's consulting relationship continues.
/s/ Fredric N. Eshelman
2011-12-19